We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Effectiveness of COVID-19 Vaccination with mRNA Vaccines for Patients with Cirrhosis in Hungary: Multicentre Matched Cohort Study.
- Authors
Drácz, Bálint; Müller, Veronika; Takács, István; Hagymási, Krisztina; Dinya, Elek; Miheller, Pál; Szijártó, Attila; Werling, Klára
- Abstract
Patients with cirrhosis are vulnerable to hepatic decompensation events and death following COVID-19 infection. Therefore, primary vaccination with COVID-19 vaccines is fundamental to reducing the risk of COVID-19 related deaths in patients with cirrhosis. However, limited data are available about the effectiveness of mRNA vaccines compared to other vaccines. The aim of our study was to investigate the efficacy of mRNA vaccines versus other vaccines in cirrhosis. In this retrospective study, we compared clinical characteristics and vaccine effectiveness of 399 COVID-19 patients without cirrhosis (GROUP A) to 52 COVID-19 patients with cirrhosis (GROUP B). 54 hospitalised cirrhosis controls without COVID-19 (GROUP C) were randomly sampled 1:1 and matched by gender and age. Of the cirrhosis cases, we found no difference (p = 0.76) in mortality rates in controls without COVID-19 (11.8%) compared to those with COVID-19 (9.6%). However, COVID-19 patients with cirrhosis were associated with higher rates of worsening hepatic encephalopathy, ascites and esophageal varices. Patients with cirrhosis receiving mRNA vaccines had significantly better survival rates compared to viral vector or inactivated vaccines. Primary vaccination with the BNT162b2 vaccine was the most effective in preventing acute hepatic decompensating events, COVID-19 infection requiring hospital admission and in-hospital mortality.
- Subjects
HUNGARY; COVID-19 vaccines; VACCINE effectiveness; COVID-19; CIRRHOSIS of the liver; COHORT analysis; ESOPHAGEAL varices; HEPATORENAL syndrome
- Publication
Vaccines, 2023, Vol 11, Issue 1, p50
- ISSN
2076-393X
- Publication type
Article
- DOI
10.3390/vaccines11010050